Selective inhibitors of nuclear export (SINE) in hematological malignancies

Experimental Hematology & Oncology
Arundhati DasDelong Liu

Abstract

Regulated nucleo-cytoplasmic transport plays a major role in maintaining cellular homeostasis. CRM1 (chromosome region maintenance 1 or exportin 1 or XPO 1) is responsible for the nucleo-cytoplasmic transport of more than 200 proteins, including most of the tumor suppressor proteins (TSP). CRM1 is overexpressed in pancreatic cancer, osteosarcoma, glioma, cervical and hematological malignancies. This inspired the development of novel agents that selectively inhibit nuclear exportins (SINEs). In this review we focus on the significance of CRM1 in carcinogenesis and review the new development of SINE inhibitiors in hematological malignancies. Selinexor (KPT-330) as the first-in-human SINE agent represents this novel class of anti-cancer agents.

References

Aug 1, 1996·British Journal of Cancer·E S NewlandsM H Brampton
Nov 11, 2008·Current Medicinal Chemistry·Joel G Turner, Daniel M Sullivan
Apr 23, 2010·Biophysical Journal·Lingling Miao, Klaus Schulten
Sep 16, 2011·Journal of Hematology & Oncology·Shinichiro Takahashi
Jun 9, 2012·Blood·Parvathi RanganathanRamiro Garzon
Jul 27, 2012·Molecular Biology of the Cell·Darui XuYuh Min Chook
Feb 14, 2013·Haematologica·Asfar S AzmiRamzi M Mohammad
Mar 28, 2013·Journal of Hematology & Oncology·Manujendra N SahaHong Chang
Apr 9, 2013·Blood·Kensuke KojimaMichael Andreeff
Oct 26, 2013·Blood·Sheela A Abraham, Tessa L Holyoake
Mar 19, 2014·Seminars in Cancer Biology·Ho Yee Joyce Fung, Yuh Min Chook
Sep 13, 2014·Journal of Hematology & Oncology·Friederike PastoreKarsten Spiekermann
Oct 5, 2014·Journal of Hematology & Oncology·Sanam LoghaviJoseph D Khoury
Oct 16, 2014·Journal of Hematology & Oncology·Kaushal ParikhDelong Liu
Dec 6, 2014·Journal of Hematology & Oncology·Giovanni Luca GravinaClaudio Festuccia

❮ Previous
Next ❯

Citations

Nov 9, 2016·Best Practice & Research. Clinical Haematology·Aneel PaulusAsher Chanan-Khan
Dec 6, 2016·Expert Opinion on Drug Discovery·Richard ArkwrightQ Ping Dou
Dec 6, 2016·Expert Review of Hematology·Heike HornGerman Ott
Sep 25, 2015·Cells·Achim DickmannsRalf Ficner
Jan 21, 2020·Expert Opinion on Pharmacotherapy·Klaus PodarSundar Jagannath
Jul 16, 2020·International Journal of Molecular Sciences·Ilaria CelaLuca Federici
Dec 22, 2017·Expert Review of Hematology·Meera Yogarajah, Richard M Stone
Nov 22, 2015·Journal of Hematology & Oncology·Shundong CangDelong Liu
Mar 10, 2016·Journal of Hematology & Oncology·Jingjing WuDelong Liu
Feb 16, 2017·Journal of Hematology & Oncology·Vincent CamusFabrice Jardin
Dec 15, 2018·Hematological Oncology·Almudena Navarro-BailónMaría Eugenia Sarasquete
Feb 28, 2019·Blood Cancer Journal·Jithma P AbeykoonThomas E Witzig
Jul 14, 2017·Frontiers in Microbiology·Cynthia Mathew, Reena Ghildyal
May 28, 2019·British Journal of Haematology·Andrzej J JakubowiakJeffrey A Zonder
Oct 23, 2016·Frontiers of Medicine·Shuhang WangDelong Liu
Aug 23, 2020·International Journal of Molecular Sciences·Sang Ah YiSo Hee Kwon
Nov 12, 2020·Nature Reviews. Drug Discovery·Giampaolo CalissiWolfgang Link
Dec 20, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dongqing YanMichael W Deininger
Mar 18, 2021·The Oncologist·Nagham Al-ZubidiAung Naing
Apr 1, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Erlene K SeymourJeffrey A Zonder
Aug 7, 2021·Journal of Personalized Medicine·Christos DamaskosDimitrios Dimitroulis

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
xenograft
biopsies

Related Concepts

Related Feeds

Autophagy & Aging: Inhibitors

The feed focuses on the role of nuclear export inhibitors and their effect on autophagy and the aging process.